Human Health Holdings Limited provided earnings guidance for the year ended 30 June 2023. For the period, the company based on the currently available information and the preliminary review of the Group's unaudited management accounts for the period, the Group is expected to record a profit attributable to owners of the Company of not more than HKD 185 million for the period as compared to the profit attributable to owners of the Company of approximately HKD 375.3 million for the year ended 30 June 2022. Based on the currently available information, the decrease in the profit attributable to owners of the Company for the year ended 30 June 2023 was primarily due to the decrease in revenue of general practice services arising from the decrease in demand for COVID-19 related preventive, testing, vaccination and outreach services; the decrease in gross profit due to the decrease in revenue of general practice services; the net fair value change on the Group's financial assets at fair value through profit or loss and investment properties which turned from a net fair value gain of approximately HKD 26 million for the year ended 30 June 2022 to a net fair value loss for the year ended 30 June 2023; and the increase in impairment of property, plant and equipment.